丽珠医药(01513)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

01513 丽珠医药

国庆日休市 09-30 16:08:27

22.720

+0.780

+3.56%

最高23.000	最低21.500	成交量438.61万
今开21.940	昨收21.940	日振幅6.84%
总市值201.75亿	流通市值68.16亿	总股本8.88亿
成交额9,889万	换手率1.46%	流通股本3.00亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"01513","market":"HK","secType":"STK","nameCN":"丽珠医药","latestPrice":22.72,"timestamp":1790755707003,"preClose":21.94,"halted":0,"volume":4386112,"delay":0,"changeRate":0.035551504102096516,"floatShares":300000000,"shares":888000000,"eps":2.27,"marketStatus":"国庆日休市","change":0.78,"latestTime":"09-30 16:08:27","open":21.94,"high":23,"low":21.5,"amount":98891414,"amplitude":0.068368,"askPrice":22.74,"askSize":1800,"bidPrice":22.72,"bidSize":5500,"shortable":3,"etf":0,"ttmEps":2.174249,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1790904600000},"marketStatusCode":7,"adr":0,"listingDate":1389801600000,"exchange":"SEHK","adjPreClose":21.94,"dividendRate":0.072302,"openAndCloseTimeList":[[1790731800000,1790740800000],[1790744400000,1790755200000]],"volumeRatio":1.688222,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"000513","market":"SZ","secType":"STK","nameCN":"丽珠集团","latestPrice":32.9,"timestamp":1790751600000,"preClose":32.23,"halted":0,"volume":46168100,"delay":0,"premium":"-40.96"}},"requestUrl":"/m/hq/s/01513","defaultTab":"news","newsList":[{"id":"1152332147","title":"丽珠医药（01513）发布股票交易异常波动公告：A股三日累积偏离20.82%","url":"https://stock-news.laohu8.com/highlight/detail?id=1152332147","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1152332147?lang=zh_cn&edition=full","pubTime":"2026-09-29 21:01","pubTimestamp":1790686885,"startTime":"0","endTime":"0","summary":"2026年9月30日，丽珠医药集团股份有限公司披露《关于股票交易异常波动的公告》。公司A股股票在2026年9月24日、9月28日及9月29日三个交易日内，收盘价格涨跌幅偏离值累计达到20.82%，符合深圳证券交易所关于“股票交易异常波动”的认定标准。公司提示投资者理性投资，注意市场风险。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01513"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671212569","title":"丽珠医药(01513)：A股股票交易异常波动 不存在应披露而未披露的重大事项","url":"https://stock-news.laohu8.com/highlight/detail?id=2671212569","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671212569?lang=zh_cn&edition=full","pubTime":"2026-09-29 20:58","pubTimestamp":1790686691,"startTime":"0","endTime":"0","summary":"智通财经APP讯，丽珠医药 发布公告，公司A股股票于2026年9月24 日、9月28日、9月29日连续3个交易日收盘价格涨跌幅偏离值累计达20.82%。根据深圳证券交易所的相关规定，属于股票交易异常波动的情况。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1502302.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["82843","01513","03188","82822","82846","02827","83130","BK1191","07233","02822","83188","BK1610","82823","399300","02843","BK1147","02846","03130","02823","159982"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1103472450","title":"丽珠医药（01513）公布2026年半年度A股现金分红实施细节 10月13日股权登记","url":"https://stock-news.laohu8.com/highlight/detail?id=1103472450","media":"公告速递","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1103472450?lang=zh_cn&edition=full","pubTime":"2026-09-29 20:11","pubTimestamp":1790683881,"startTime":"0","endTime":"0","summary":"丽珠医药集团股份有限公司9月30日披露2026年半年度A股权益分派实施公告。公司2026年第一次临时股东会已于9月24日审议通过利润分配方案，本次派息面向持有公司A股的全体股东。根据公告，本次现金分红以实施股权登记日的总股本为基数，不含已回购但未注销股份。截至公告披露日，公司总股本为887,907,171股，其中A股股本为588,100,054股。A股股权登记日为2026年10月13日，除权除息日为2026年10月14日。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01513"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671921510","title":"丽珠医药(01513)：注射用醋酸亮丙瑞林微球11.25mg(3个月剂型)获得《药品补充申请批准通知书》","url":"https://stock-news.laohu8.com/highlight/detail?id=2671921510","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671921510?lang=zh_cn&edition=full","pubTime":"2026-09-29 18:52","pubTimestamp":1790679134,"startTime":"0","endTime":"0","summary":"智通财经APP讯，丽珠医药 发布公告，近日，公司的控股子公司上海丽珠制药有限公司收到国家药品监督管理局核准签发的《药品补充申请批准通知书》，上海丽珠生产的注射用醋酸亮丙瑞林微球11.25mg获批上市。截至本公告披露日，注射用醋酸亮丙瑞林微球已累计投入的直接研发费用约为人民币9405.48万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1502176.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"丽珠医药(01513)：注射用醋酸亮丙瑞林微球11.25mg(3个月剂型)获得《药品补充申请批准通知书》","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01513","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671215101","title":"丽珠医药(01513.HK)：注射用醋酸亮丙瑞林微球11.25mg(3个月剂型)获得《药品补充申请批准通知书》","url":"https://stock-news.laohu8.com/highlight/detail?id=2671215101","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671215101?lang=zh_cn&edition=full","pubTime":"2026-09-29 18:52","pubTimestamp":1790679134,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1191","01513"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1181776097","title":"丽珠医药（01513）旗下11.25mg三月剂型亮丙瑞林微球获批上市","url":"https://stock-news.laohu8.com/highlight/detail?id=1181776097","media":"公告速递","labels":["productRelease","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1181776097?lang=zh_cn&edition=full","pubTime":"2026-09-29 18:50","pubTimestamp":1790679059,"startTime":"0","endTime":"0","summary":"2026年9月29日，丽珠医药集团股份有限公司公告称，其控股子公司上海丽珠制药有限公司已收到国家药品监督管理局签发的《药品补充申请批准通知书》，批准注射用醋酸亮丙瑞林微球11.25mg在国内上市，核发药品批准文号“国药准字H20269239”，有效期至2029年4月27日。此次获批标志着该规格新增至已上市的3.75mg、1.88mg后，丽珠医药在国内实现了注射用醋酸亮丙瑞林微球全规格覆盖。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"a3893e2538b44a4c9453f52433cb6ed2","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01513"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1139670209","title":"丽珠医药（01513）2026年首场临时股东会合法合规　利润分配方案高票通过","url":"https://stock-news.laohu8.com/highlight/detail?id=1139670209","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1139670209?lang=zh_cn&edition=full","pubTime":"2026-09-28 07:33","pubTimestamp":1790552035,"startTime":"0","endTime":"0","summary":"2026年9月24日，丽珠医药召开2026年第一次临时股东大会。会议经广东崇立律师事务所出具法律意见书确认，召集、召开程序及表决结果符合《公司法》《上市公司股东大会规则》等相关法规及《丽珠医药集团股份有限公司章程》规定，所作决议合法有效。本次股东大会共有股东及委托代理人591人出席，合计持有有表决权股份440,351,829股，占公司有表决权股份总数的49.5944%。根据表决结果，该利润分配方案获得通过。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01513"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670700914","title":"丽珠医药于将于11月3日派发特别中期股息每10股10.2元","url":"https://stock-news.laohu8.com/highlight/detail?id=2670700914","media":"新浪港股","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2670700914?lang=zh_cn&edition=full","pubTime":"2026-09-27 13:24","pubTimestamp":1790486640,"startTime":"0","endTime":"0","summary":"热点栏目自选股\n数据中心\n行情中心\n资金流向\n模拟交易客户端丽珠医药（01513）发布公告，该公司将于2026年11月3日派发特别中期股息每10股10.2元。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2026-09-27/doc-initfxsc9580084.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4585","01513","BK4588","VIG","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1185622314","title":"丽珠医药（01513）副总裁徐晓辞任 仍将留任公司其他职务","url":"https://stock-news.laohu8.com/highlight/detail?id=1185622314","media":"公告速递","labels":["executive","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1185622314?lang=zh_cn&edition=full","pubTime":"2026-09-24 19:16","pubTimestamp":1790248564,"startTime":"0","endTime":"0","summary":"丽珠医药集团股份有限公司9月24日公告称，董事会已于2026年9月23日收到副总裁徐晓先生的书面辞职报告。徐晓先生因工作调整原因，申请辞去副总裁职务，辞任自送达董事会之日起生效，并将继续在公司担任其他职务。截至公告日，徐晓先生未持有公司股份。\\n\\n董事会表示，徐晓先生在任职副总裁期间恪尽职守、勤勉尽责，其辞任不会影响公司正常运营。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01513"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669462205","title":"丽珠医药(01513)：徐晓辞任副总裁","url":"https://stock-news.laohu8.com/highlight/detail?id=2669462205","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669462205?lang=zh_cn&edition=full","pubTime":"2026-09-24 19:12","pubTimestamp":1790248372,"startTime":"0","endTime":"0","summary":"智通财经APP讯，丽珠医药(01513)发布公告，董事会宣布于2026年9月23日收到副总裁徐晓先生的书面辞职报告。因工作调整原因，徐先生申请辞去公司副总裁职务，辞任后仍在公司担任其他职务。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1500655.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01513","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1117492529","title":"丽珠医药(01513)特别中期股息获股东会高票通过 每10股派息10.20元共计9.06亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=1117492529","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1117492529?lang=zh_cn&edition=full","pubTime":"2026-09-24 19:11","pubTimestamp":1790248303,"startTime":"0","endTime":"0","summary":"丽珠医药集团股份有限公司9月24日公告称，公司于2026年9月24日召开2026年第一次临时股东会，审议并通过2026年回报股东之特别中期股息等议案。临时股东会当日，公司共有股东及代理人591名出席会议，合计代表有表决权股份440,351,829股，占公司总股本887,907,171股的49.5944%。其中，A股股东及代理人持有254,819,556股，占比28.6989%；H股股东及代理人持有185,532,273股，占比20.8955%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01513"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669462283","title":"丽珠医药(01513.HK)将于11月3日派发特别中期股息每10股10.2元","url":"https://stock-news.laohu8.com/highlight/detail?id=2669462283","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669462283?lang=zh_cn&edition=full","pubTime":"2026-09-24 19:11","pubTimestamp":1790248273,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["01513","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669745161","title":"港股异动 | 丽珠医药(01513)午前涨近4% 近日参股公司毛孩子®多西环素内服糊剂获批上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2669745161","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669745161?lang=zh_cn&edition=full","pubTime":"2026-09-23 11:25","pubTimestamp":1790133953,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，丽珠医药午前涨近4%，截至发稿，涨3.67%，报21.46港元，成交额1789.48万港元。消息面上，据丽珠医药官微消息，近日，丽珠医药参股公司毛孩子动保宣布，其自主研发的毛孩子多西环素内服糊剂正式获批上市。毛孩子多西环素内服糊剂主要成分为多西环素一水合物，其水溶液pH值接近中性，食道灼伤风险低。该原料药由丽珠医药自研，有助于实现从原料到制剂的全链路品质把控。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1499704.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4588","KCAI","VXUS","BK4585","01513","BK1191","IPOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1177265488","title":"丽珠医药(01513)董事会拟增补朱琳琳为非独立董事","url":"https://stock-news.laohu8.com/highlight/detail?id=1177265488","media":"公告速递","labels":["executive","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1177265488?lang=zh_cn&edition=full","pubTime":"2026-09-18 16:53","pubTimestamp":1789721611,"startTime":"0","endTime":"0","summary":"丽珠医药集团股份有限公司9月19日公告披露，公司第十二届董事会第五次会议已于2026年9月18日以通讯方式召开，会议通知于9月15日通过电子邮件发出，9名董事全部出席，会议程序符合相关法律法规及《公司章程》规定。会议审议并全票通过《关于选举公司第十二届董事会非独立董事的议案》，同意提名朱琳琳女士为公司第十二届董事会非独立董事候选人，任期自股东大会审议通过之日起至本届董事会任期届满之日止。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01513"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1178549489","title":"丽珠医药（01513）拟聘朱琳琳为非执行董事 年薪9.6万元","url":"https://stock-news.laohu8.com/highlight/detail?id=1178549489","media":"公告速递","labels":["executive","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1178549489?lang=zh_cn&edition=full","pubTime":"2026-09-18 16:52","pubTimestamp":1789721522,"startTime":"0","endTime":"0","summary":"9月18日，丽珠医药集团股份有限公司公告称，董事会已审议通过提名朱琳琳为公司第十二届董事会非执行董事候选人。2022年4月至2023年3月，朱琳琳任健康元药业集团股份有限公司健康品事业部市场副总监。如其任命获临时股东大会通过，公司将与朱琳琳签订董事服务合约，其在任期内每年将收取税前年薪人民币9.6万元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01513"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668737949","title":"丽珠医药(01513.HK)建议委任朱琳琳为非执行董事","url":"https://stock-news.laohu8.com/highlight/detail?id=2668737949","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2668737949?lang=zh_cn&edition=full","pubTime":"2026-09-18 16:48","pubTimestamp":1789721290,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1191","01513"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1187459068","title":"丽珠医药(01513)董事会选举刘大平为董事长并调整专门委员会","url":"https://stock-news.laohu8.com/highlight/detail?id=1187459068","media":"公告速递","labels":["executive","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1187459068?lang=zh_cn&edition=full","pubTime":"2026-09-11 20:11","pubTimestamp":1789128717,"startTime":"0","endTime":"0","summary":"丽珠医药集团股份有限公司9月12日公告称，公司第十二届董事会第四次会议已于2026年9月11日以通讯方式召开，应出席董事9人，实际全部出席，符合相关法规及《公司章程》规定。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01513"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1193413703","title":"丽珠医药（01513）披露最新董事会及专门委员会成员构成","url":"https://stock-news.laohu8.com/highlight/detail?id=1193413703","media":"公告速递","labels":["executive","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1193413703?lang=zh_cn&edition=full","pubTime":"2026-09-11 20:11","pubTimestamp":1789128715,"startTime":"0","endTime":"0","summary":"2026年9月11日，丽珠医药集团股份有限公司公布现任董事在董事会及其五个专门委员会的任职情况。公司董事会成员及其职务如下：。截至公告日，上述安排已正式生效。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01513"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1148449675","title":"丽珠医药（01513.HK）发布高层人事变动：刘大平接任董事长并兼任总裁","url":"https://stock-news.laohu8.com/highlight/detail?id=1148449675","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1148449675?lang=zh_cn&edition=full","pubTime":"2026-09-11 20:11","pubTimestamp":1789128703,"startTime":"0","endTime":"0","summary":"9月11日，丽珠医药集团股份有限公司公告称，自2026年9月11日起，公司董事长、非执行董事朱保国因退休辞去董事长、非执行董事、战略委员会主席及环境、社会及管治委员会主席职务，并不再担任公司法定代表人及集团任何职务。朱保国确认其与董事会无意见分歧，且无其他需提请股东注意的事项。刘大平现年39岁，已就担任执行董事、董事长及总裁与公司分别签署服务合约。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01513"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666521705","title":"丽珠医药(01513.HK)委任刘大平为董事长","url":"https://stock-news.laohu8.com/highlight/detail?id=2666521705","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666521705?lang=zh_cn&edition=full","pubTime":"2026-09-11 20:01","pubTimestamp":1789128110,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["01513","BK1191"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.livzon.com.cn","stockEarnings":[{"period":"1week","weight":0.0432},{"period":"1month","weight":0.1429},{"period":"3month","weight":-0.0666},{"period":"6month","weight":-0.1708},{"period":"1year","weight":-0.3006},{"period":"ytd","weight":-0.151}],"compareEarnings":[{"period":"1week","weight":-0.0089},{"period":"1month","weight":-0.0373},{"period":"3month","weight":0.0676},{"period":"6month","weight":-0.02},{"period":"1year","weight":-0.0835},{"period":"ytd","weight":-0.0397}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"丽珠医药集团股份有限公司是一家主要从事医药产品的研发、生产及销售业务的中国公司。该公司的主要业务包括化学制剂、生物制品、原料药及中间体、中药制剂、诊断试剂和设备，以及商业发展和职能管理。该公司的主要产品品牌包括“壹丽安”（艾普拉唑肠溶片及注射用艾普拉唑钠）、“丽珠得乐”（枸橼酸铋钾）系列产品、“丽倍乐”（雷贝拉唑钠肠溶胶囊）、“维三联”（枸橼酸铋钾片/替硝唑片/克拉霉素片）、“贝依”（注射用醋酸亮丙瑞林微球）、“丽申宝”（注射用尿促卵泡素）、“乐宝得”（注射用尿促性素）、“丽福康”（注射用伏立康唑）等。该公司主要在中国国内和海外市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.416667,"avgChangeRate":0.001127},{"month":2,"riseRate":0.538462,"avgChangeRate":0.025406},{"month":3,"riseRate":0.538462,"avgChangeRate":0.02244},{"month":4,"riseRate":0.692308,"avgChangeRate":0.031866},{"month":5,"riseRate":0.384615,"avgChangeRate":0.007594},{"month":6,"riseRate":0.461538,"avgChangeRate":-0.00234},{"month":7,"riseRate":0.461538,"avgChangeRate":-0.010332},{"month":8,"riseRate":0.461538,"avgChangeRate":-0.017344},{"month":9,"riseRate":0.5,"avgChangeRate":0.022838},{"month":10,"riseRate":0.363636,"avgChangeRate":-0.019818},{"month":11,"riseRate":0.583333,"avgChangeRate":0.034244},{"month":12,"riseRate":0.5,"avgChangeRate":-0.008144}],"exchange":"SEHK","name":"丽珠医药","nameEN":"LIVZON PHARMA"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"丽珠医药(01513)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供丽珠医药(01513)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"丽珠医药,01513,丽珠医药股票,丽珠医药股票老虎,丽珠医药股票老虎国际,丽珠医药行情,丽珠医药股票行情,丽珠医药股价,丽珠医药股市,丽珠医药股票价格,丽珠医药股票交易,丽珠医药股票购买,丽珠医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"丽珠医药(01513)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供丽珠医药(01513)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}